The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4

Annals of the New York Academy of Sciences

Volumn 1112, Issue , 2007, Pages 140-153

  Kater, Arnon ^a   Henke, Markus O ^b   Rubin, Bruce K ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Actin; Cystic fibrosis; DNA; Gelsolin; Mucin; Mucus; Pus; Rheology; Sputum; Thymosin beta 4

Indexed keywords

DNA; DORNASE ALFA; EXCIPIENT; F ACTIN; GELSOLIN; POLYMER; THYMOSIN BETA4;

ACTIN POLYMERIZATION; ADOLESCENT; ADULT; BRONCHUS MUCOSA; BRONCHUS MUCUS; BRONCHUS SECRETION; CELL DEATH; CILIARY MOTILITY; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTIC FIBROSIS; DEPOLYMERIZATION; DNA DETERMINATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FLOW KINETICS; HUMAN; INCUBATION TIME; INFLAMMATORY CELL; MALE; MUCOCILIARY CLEARANCE; MUCOCILIARY TRANSPORT; PROTEIN FUNCTION; PUS; SPUTUM ANALYSIS; STRUCTURE ANALYSIS; VISCOELASTICITY;

EID: 35349014567     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1415.006     Document Type: Conference Paper

References (66)

1. RUBIN, B.K. & M. KING. 1996. Mucus physiology and pathophysiology: therapeutic aspects. In Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease. J.P. Derenne, T. Similowski, & W.A. Whitelaw, Eds.: 391-411. Marcel Dekker. New York.
2. KNOWLES, M.R., & R.C. BOUCHER. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109: 571-577.
3. GIROD, S., J.M. ZAHM, C. PLOTKOWSKI, et al. 1992. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium. Eur. Respir. J. 5: 477-487.
4. THORNTON, D.J., J.R. DAVIES, M. KRAAYENBRINK, et al. 1990. Mucus glycoproteins from 'normal' human tracheobronchial secretion. Biochem. J. 265: 179-186.
5. TOMKIEWICZ, R.P., C. KISHIOKA, J. FREEMAN, et al.1998. DNA and actin filament ultrastructure in cystic fibrosis sputum. In Cilia, Mucus, and Mucociliary Interactions. G. Baum Ed.: 333-341. Marcel Dekker. New York
6. LETHEM, M.I., S.L. JAMES, C. MARRIOTT, et al. 1990. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur. Respir. J. 3: 19-23.
7. AGARWAL, M., M. KING, B.K. RUBIN, et al. 1989. Mucus transport in a miniaturized simulated cough machine: effect of constriction and serous layer simulant. Biorheology 26: 977-988.
8. THORNTON, D.J., J.K. SHEEHAN, H. LINDGREN, et al. 1991. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'. Biochem. J. 276: 667-675.
9. KING, M. & B.K. RUBIN. 1994. Mucus rheology: relationship with transport. In Airway Secretion: Physiological Basis for the Control of Mucus Hypersecretion. T. Takishima & S. Shimura, Eds.: 283-314. Marcel Dekker New York.
10. BOAT, T.F., P.W. CHENG, R.N. IYER, et al. 1976. Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch. Biochem. Biophys. 177: 95-104.
11. ROSE, M.C., C.F. BROWN, J.Z. JACOBY, III, et al. 1987. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals. Pediatr. Res. 22: 545-551.
12. HENKE, M.O., A. RENNER, R.M. HUBER, et al. 2004. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am. J. Respir. Cell Mol. Biol. 31: 86-91.
13. HOVENBERG, H.W., J.R. DAVIES, A. HERRMANN, et al. 1996. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj. J. 13: 839-847.
14. HOVENBERG, H.W., J.R. DAVIES & I. CARLSTEDT. 1996. Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 318: 319-324.
15. GRONEBERG, D.A., P.R. EYNOTT, T. OATES, et al. 2002. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir. Med. 96: 81-86.
16. SHEEHAN, J.K., M. HOWARD, P.S. RICHARDSON, et al. 1999. Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug. Biochem. J. 338: 507-513.
17. HENKE, M.O., G. JOHN, M. GERMANN, et al. 2007. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am. J. Respir. Crit. Care Med. 175: 816-821.
18. GARDEL, M.L., J.H. SHIN, F.C. MACKINTOSH, et al. 2004. Elastic behavior of cross-linked and bundled actin networks. Science 304: 1301-1305.
19. KING, M., B. DASGUPTA, R. TOMKIEWICZ, et al. 1997. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease. Am. J. Resp. Crit. Care Med. 156: 173-177.
20. SHAH, S.A., P. SANTAGO, & B.K. RUBIN. 2005. Quantification of biopolymer filament structure. Ultramicroscopy 104: 244-254.
21. RUBIN, B.K., A.P. KATER & A.L. GOLDSTEIN. 2006. Thymosin beta 4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro. Chest 130: 1433-1440.
22. VASCONCELLOS, C.A., P.G. ALLEN, M.E. WOHL, et al. 1994. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263: 969-971.
23. SHEILS, C.A., J. KAS, W. TRAVASSOS, et al. 1996. Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am. J. Path. 148: 919-927.
24. SANDERS, M.C., A.L. GOLDSTEIN & Y.-L. WANG. 1992. Thymosin ß4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc. Natl. Acad. Sci. USA 89: 4678-4682.
25. SAFER, D. & V.T. NACHMIAS. 1994. Beta thymosins as actin binding peptides. BioEssays 16: 473-479.
26. CARLIER, M.-F., D. DIDRY, I. ERK, et al. 1996. Thymosin beta 4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentration. J. Biol. Chem. 271: 9231-9239.
27. RUBIN, B.K., O. RAMIREZ, J.G. ZAYAS, et al. 1990. Collection and analysis of respiratory mucus from subjects without lung disease. Am. Rev. Respir. Dis. 141: 1040-1043.
28. RUBIN, B.K., O. RAMIREZ, J.G. ZAYAS, et al. 1992. Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action. Am. Rev. Respir. Dis. 145: 545-547.
29. RUBIN, B.K., B. FINEGAN, O. RAMIREZ, et al. 1990. General anesthesia does not alter the viscoelastic or transport properties of human respiratory mucus. Chest 98: 101-104.
30. SHAH, P.L., S.F. SCOTT, R.A. KNIGHT, et al. 1996. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 51: 119-125.
31. KISHIOKA, C., K. OKAMOTO, J.-S. KIM, et al. 2001. Regulation of secretion from mucous and serous cells in the excised ferret trachea. Resp. Physiol. 2001: 126: 163-171.
32. AUBUCHON, S.R. & B.K. RUBIN. 1998. Application of Viscoelastic Transformations to Rheological Analysis of Human Biological Fluids. TA Instruments, New Castle, DE.
33. ZAHM, J.M., E. PUCHELLE, C. DUVIVIER, et al. 1986. Spinability of respiratory mucous. Validation of a new apparatus: the Filancemeter. Bulletin Europ. de Physiopathologie Respir. 22: 609-613.
34. DENTON, R. 1960. Bronchial obstruction in cystic fibrosis: rheological factors. Pediatrics 25: 611-620.
35. PICOT, R., I. DAS & L. REID. 1978. Pus, deoxyribonucleic acid, and sputum viscosity. Thorax 33: 235-242.
36. SHAK, S., D.J. CAPON, R. HELLMISS, et al. 1990. Recombinant human DNase-I reduces the viscosity of cystic fibrosis sputum. Proc. Natl. Acad. Sci. USA 87: 9188-9192.
37. BURGI, H. 1974. Fiber systems in sputum. Scand. J. Respir. Dis. 21-25.
38. ARMSTRONG, J.B. & J.C. WHITE. 1950. Liquefaction of viscous purulent exudates by deoxyribonuclease. Lancet 2: 739-742.
39. ELMES, P.C. & J.C. WHITE. 1953. Deoxyribonuclease in the treatment of purulent bronchitis. Thorax 8: 295-300.
40. FEATHER, E.A. & G. RUSSELL. 1970. Sputum viscosity and pulmonary function in cystic fibrosis. Arch. Dis. Child. 45: 807-808.
41. PALMER, K.N., D. BALLANTYNE, M.L. DIAMENT, et al. 1970. The rheology of bronchitic sputum. Br. J Dis. Chest 64: 185-191.
42. ROBINSON, W., P.B. WOOLLEY & R.E. ALTOUNYAN. 1958. Reduction of sputum viscosity in chronic bronchitis. Lancet 2: 819-821.
43. ZAHM, J.M., C. DEBORDEAUX, C. MAURER, et al. 2001. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions. Am. J. Respir. Crit. Care Med. 163: 1153-1157.
44. PUCHELLE, E., J.M. ZAHM, S. DE BENTZMANN, et al. 1996. Effects of rhDNase on purulent airway secretions in chronic bronchitis. Eur. Respir. J. 9: 765-769.
45. DENEUVILLE, E., C. PERROT-MINOT, F. PENNAFORTE, et al. 1997. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients. Am. J. Respir. Crit. Care Med. 156: 166-172.
46. PUCHELLE, E., J. JACQUOT, G. BECK, et al. 1985. Rheological and transport properties of airway secretions in cystic fibrosis - relationships with the degree of infection and severity of the disease. Eur. J. Clin. Invest. 15: 389-394.
47. ZAHM, J.M., D. PIERROT, S. VAQUEZ-G IROD, et al. 1989. The role of mucus sol phase in clearance by simulated cough. Biorheology 26: 747-752.
48. ZAHM, J.M., S. DE BENTZMANN, E. DENEUVILLE, et al. 1995. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus. Eur. Respir. J. 8: 381-386.
49. LETHEM, M.I., S.L. JAMES & C. MARRIOTT. 1990. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum. Am. Rev. Respir. Dis. 142: 1053-1058.
50. BORNSTEIN, A.A., T.M. CHEN & M.J. DULFANO. 1978. Disulfide bonds and sputum viscoelasticity. Biorheology 15: 261-267.
51. GALABERT, C., J. JACQUOT, J.M. ZAHM, et al. 1987. Relationships between the lipid-content and the rheological properties of airway secretions in cystic-fibrosis. Clin. Chim. Acta 164: 139-149.
52. KING, M., J.M. ZAHM, D. PIERROT, et al. 1989. The role of mucus gel viscosity, spinnability, and adhesive properties in clearance by simulated cough. Biorheology 26: 737-745.
53. ZAHM, J.M., C. GALABERT, A. CHAFFIN, et al. 1998. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile. Am. J. Respir. Crit. Care Med. 157: 1779-1784.
54. NIELSEN, H., S. HVIDT, C.A. SHEILS, et al. 2004. Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients. Biophys. Chem. 112: 193-200.
55. KING, M. 1980. Rheological requirements for optimal clearance of secretions: ciliary transport versus cough. Eur. J. Respir. Dis. Suppl 110: 39-45.
56. KING, M., G. BROCK & C. LUNDELL. 1985. Clearance of mucus by simulated cough. J. Appl. Physiol. 58: 1776-1782.
57. DE SANCTIS, G.T., R.P. TOMKIEWICZ, B.K. RUBIN, et al. 1994. Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog. Eur. Respir. J. 7: 1616-1621.
58. NIELSEN, H., S. HVIDT, C.A. SHEILS, et al. 2004. Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients. Biophys. Chem. 112: 193-200.
59. RUBIN, B.K. 1999. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol. Chest 116: 195-200.
60. TANG, J.X., Q. WEN, A. BENNETT, et al. 2005. Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am. J. Physiol. Lung Cell Mol. Physiol. 289: L599-L605.
61. DENTON, R., W. FORSMAN, S.H. HWANG, et al. 1968. Viscoelasticity of mucus. Its role in ciliary transport of pulmonary secretions. Am. Rev. Respir. Dis. 98: 380-391.
62. KING, M. 1987. Role of mucus viscoelasticity in clearance by cough. Eur. J. Respir. Dis. Suppl 153: 165-172.
63. FERRY, J.D. 1970. Molecular theory for undiluted polymers and concentrated solutions: Networks and entanglements. In Viscoelastic Properties of Polymers. Second edition.. 268-270. Wiley. New York.
64. DAVOODIAN, K., B.W. RITCHINGS, R. RAMPHAL, et al. 1997. Gelsolin activates DNase I in vitro in cystic fibrosis sputum. Biochemistry 36: 9637-9641.
65. LAZARIDES, E. & U. LINDBERG. 1974. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc. Natl. Acad. Sci. 71: 4742-4746.
66. SHAH, S.A. 2006. Biophysical characterization of secretions in airway disease and its relation to cough clearance. Ph.D. dissertation, Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Winston-Salem, NC.